Antibiotics in Blood Can Make Malaria Mosquitoes Mightier

The drugs disrupt mosquitoes' gut bacteria, which appears to make the insects more effective malaria vectors. Christopher Intagliata reports

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


It's well known that antibiotics can disrupt our gut bacteria. But when mosquitoes snack on blood laced with antibiotics, the same can happen to their microbiome. And that depletion of gut bacteria actually increases mosquitoes' susceptibility to the malaria parasite. Meaning they may be more likely to host and then spread the disease-causing protozoan. That's according to a study in the journal Nature Communications. [Mathilde Gendrin et al, Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria]

Researchers fed mosquitoes the blood of children infected with the malaria parasite. They added a penicillin-streptomycin antibiotic cocktail to some samples, and a control solution to others. Turns out the mosquitoes that sucked the blood doped with antibiotics were more likely to pick up the parasite. And those mosquitoes appeared to gain some benefit from the antibiotics too—they lived longer and had more offspring than the other mosquitoes in the tests. So these commonly used antibiotics made the insects a more powerful vector for malaria.

Some antibiotics, of course, do inhibit malaria transmission. Doxycycline, for example, is sometimes taken as a malaria prophylactic. 

"Different antibiotics may have different impacts. Which could translate into an opposite effect than what we demonstrated in the paper." Study author George Christophides, of Imperial College London. 

He says this interaction is especially worth considering for patients with malaria as well as tuberculosis or HIV—because treatment of those conditions can involve receiving antibiotics for months. "TB and HIV prevalence in malaria-endemic countries is huge. So if all these people are taking antibiotics, we must know what they do on malaria transmission." Christophides and his colleagues are now investigating those connections—to make sure certain antibiotics don't turn the mosquito into a whole new kind of 'superbug.'

—Christopher Intagliata

[The above text is a transcript of this podcast.]

[Scientific American is part of Nature Publishing Group.]
 

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe